NEWS: Today we are thrilled to announce the oversubscribed final close of Ada Ventures Fund II at £63m/$80m. The £63m/$80m fund is dedicated to breakthrough ideas across the fund’s three themes: climate equity, healthy ageing and economic empowerment. We will continue to make pre-seed and seed investments between £250k and £1.5m And we’re already on our way. Our investment team has partnered with 11 new companies across the UK including, @Blakbear_, @MaterialsNexus, @Openformat_tech, @wearejunobio, @PlannerPalAI, MultiOmic, @glowb_uk, BOLDR, @greenworkx_ and Radiant Matter. A big thank you to the LPs who joined Ada Ventures Fund II including @BritishBBank, @EdinburghUni, @BigSocietyCap, @landg_group, @atomico, @Eifo_fond and @MoltenVentures. They have been joined by a number of founder investors, including @taavet, co-founder of Wise, and Illusian, family office co-founded by @ipaananen, co-founder and CEO of Supercell. To follow the story, see the links in the thread below👇

This article is part of a series profiling the founders aligned with our Inclusive Alpha® investment approach. Read Breaking bottlenecks: Why Research Grid is revolutionising clinical trials 👇🏾diarrasmith.medium.com/break… 👈🏾 For @AmberMichelleH her drive to found @researchgrid was borne of personal experience. Prior to starting the company, she was a medical research expert with a PhD in Biomedical Neuroscience from UCL. “It’s madness that we have some of the smartest people in the world wasting hundreds of hours on admin, filling in forms and tables.” Dr Hill is also driven by a desire to tackle some of the inequalities present in the healthcare outcomes system today. “I want to bring more people into clinical trials. More women, greater age ranges, and more diverse groups in terms of race and ethnicity.”